Cardiorenometabolic syndrome stage 2–3 in self-independent elderly patients

Objective. To characterize the clinical and laboratory characteristics of patients aged 60–74 years with stage 2–3 cardiorenometabolic syndrome (CKM) and a retrospective assessment of 15-year follow-up. Materials and methods. Anthropometric, laboratory and instrumental examination data of patients contained in the medical records of 73 overweight/obese patients with arterial hypertension aged 60–74 years without clinical cardiovascular clinical diseases (CKM stage 2 and 3). Results and discussion. The incidence of diabetes/prediabetes was 20.5 % (95 % CI (12.9–31.2)), metabolic syndrome was 64.4 % (95 % CI (52.9–74.4)). The TyG index in patients with metabolic syndrome ranged from 7.78 to 11.83, median (Me) and interquartile interval [Q1; Q3] were 8.84 and [8.53; 9.13] and exceeded the results of patients without metabolic syndrome (Mann – Whitney test z = 4.018413, p = 0.0001). In 44.9 % of patients, the serum uric acid level was equal to or greater than 360 μmol/L. The growth rate over 15 years was 106 % for obesity (6 % increase), 202 % for hypertension (102 % increase), and 500 % for diabetes mellitus (400 % increase). Over a 10-year period, the structure CKD-EPI ≥ 60/˂ 60 mL/min/1,73м 2 ranged from 80/20 % to 65/35 %. Conclusion. The study gives an idea of the frequency and 15-year dynamics without progression to CKM stage 4 in the elderly under the conditions of observation by the media service of an industrial enterprise.